COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03662815
Recruitment Status : Active, not recruiting
First Posted : September 7, 2018
Last Update Posted : September 4, 2019
Hangzhou Neoantigen Therapeutics Co., Ltd.
Information provided by (Responsible Party):
Yong Fang, Sir Run Run Shaw Hospital

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : March 2021